Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Oct;104(2):478–482. doi: 10.1111/j.1476-5381.1991.tb12454.x

Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine.

D Schneider 1, E Schlicker 1, B Malinowska 1, G Molderings 1
PMCID: PMC1908572  PMID: 1665738

Abstract

1. Segments of the rat vena cava preincubated with [3H]-noradrenaline were superfused with [3H]-noradrenaline-free solution containing desipramine and corticosterone and the effects of gamma-aminobutyric acid (GABA) receptor ligands and of histamine on tritium overflow evoked by transmural electrical stimulation were studied. 2. GABA inhibited, and histamine failed to affect, the electrically (0.66 Hz) evoked tritium overflow both in the absence and presence of rauwolscine (which was present in the superfusion medium in the subsequent experiments). The effect of GABA was less pronounced at a stimulation frequency of 2 Hz. 3. The inhibitory effect of GABA (pIC35 5.83) on the electrically (0.66 Hz) evoked overflow was mimicked by the GABAB receptor agonist, R-(-)-baclofen (6.07) and less potently by S-(+)-baclofen (3.30) and the GABAA receptor agonist, muscimol (3.70). The concentration-response curve of GABA was shifted to the right by the GABAB receptor antagonist, CGP 35348 (P-(3-aminopropyl)-P- diethoxymethyl-phosphinic acid; apparent pA2 4.76), but not affected by the GABAA receptor antagonist, (-)-bicuculline methiodide 100 mumol l-1. Given alone, (-)-bicuculline methiodide slightly increased, and CGP 35348 did not affect, the evoked overflow. 4. The effect of GABA in veins from rats treated for 14 days with RS-baclofen (10 mg kg-1, i.p. once daily) did not differ from that in veins from rats which received the vehicle instead. The effect of GABA also did not differ in veins from rats treated once either with RS-baclofen or with its vehicle.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
478

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anwar N., Mason D. F. Two actions of gamma-aminobutyric acid on the responses of the isolated basilar artery from the rabbit. Br J Pharmacol. 1982 Jan;75(1):177–181. doi: 10.1111/j.1476-5381.1982.tb08770.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartolini A., Giotti A., Giuliani S., Malmberg-Aiello P., Patacchini R. Bicuculline actions on isolated rat atria, mouse vas-deferens and guinea-pig ileum are unrelated to GABA A receptor blockade. Gen Pharmacol. 1990;21(3):277–284. doi: 10.1016/0306-3623(90)90822-4. [DOI] [PubMed] [Google Scholar]
  3. Baumann P. A., Wicki P., Stierlin C., Waldmeier P. C. Investigations on GABAB receptor-mediated autoinhibition of GABA release. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):88–93. doi: 10.1007/BF00195063. [DOI] [PubMed] [Google Scholar]
  4. Bowery N. G., Hill D. R., Hudson A. L. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. Br J Pharmacol. 1983 Jan;78(1):191–206. doi: 10.1111/j.1476-5381.1983.tb09380.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Erdö S. L., Wolff J. R. gamma-Aminobutyric acid outside the mammalian brain. J Neurochem. 1990 Feb;54(2):363–372. doi: 10.1111/j.1471-4159.1990.tb01882.x. [DOI] [PubMed] [Google Scholar]
  6. Göthert M., Kollecker P. Subendothelial beta 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis. Naunyn Schmiedebergs Arch Pharmacol. 1986 Oct;334(2):156–165. doi: 10.1007/BF00505816. [DOI] [PubMed] [Google Scholar]
  7. Göthert M., Schlicker E., Kollecker P. Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat. Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):124–130. doi: 10.1007/BF00511401. [DOI] [PubMed] [Google Scholar]
  8. Heyer E. J., Nowak L. M., Macdonald R. L. Bicuculline: a convulsant with synaptic and nonsynaptic actions. Neurology. 1981 Nov;31(11):1381–1390. doi: 10.1212/wnl.31.11.1381. [DOI] [PubMed] [Google Scholar]
  9. Hills J. M., Larkin M. M., Howson W. A comparison of the relative activities of a number of GABAB antagonists in the isolated vas deferens of the rat. Br J Pharmacol. 1991 Mar;102(3):631–634. doi: 10.1111/j.1476-5381.1991.tb12224.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hills J. M., Sellers A. J., Mistry J., Broekman M., Howson W. Phosphinic acid analogues of GABA are antagonists at the GABAB receptor in the rat anococcygeus. Br J Pharmacol. 1991 Jan;102(1):5–6. doi: 10.1111/j.1476-5381.1991.tb12121.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ishikawa S., Sperelakis N. A novel class (H3) of histamine receptors on perivascular nerve terminals. Nature. 1987 May 14;327(6118):158–160. doi: 10.1038/327158a0. [DOI] [PubMed] [Google Scholar]
  12. Kohlenbach A., Schlicker E. GABAB receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Br J Pharmacol. 1990 Jun;100(2):365–369. doi: 10.1111/j.1476-5381.1990.tb15810.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Manzini S., Maggi C. A., Meli A. Inhibitory effect of GABA on sympathetic neurotransmission in rabbit ear artery. Arch Int Pharmacodyn Ther. 1985 Jan;273(1):100–109. [PubMed] [Google Scholar]
  14. Miranda F. J., Torregrosa G., Salom J. B., Campos V., Alabadí J. A., Alborch E. Inhibitory effect of GABA on cerebrovascular sympathetic neurotransmission. Brain Res. 1989 Jul 17;492(1-2):45–52. doi: 10.1016/0006-8993(89)90887-1. [DOI] [PubMed] [Google Scholar]
  15. Molderings G. J., Fink K., Schlicker E., Göthert M. Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava. Naunyn Schmiedebergs Arch Pharmacol. 1987 Sep;336(3):245–250. doi: 10.1007/BF00172673. [DOI] [PubMed] [Google Scholar]
  16. Olpe H. R., Karlsson G., Pozza M. F., Brugger F., Steinmann M., Van Riezen H., Fagg G., Hall R. G., Froestl W., Bittiger H. CGP 35348: a centrally active blocker of GABAB receptors. Eur J Pharmacol. 1990 Oct 2;187(1):27–38. doi: 10.1016/0014-2999(90)90337-6. [DOI] [PubMed] [Google Scholar]
  17. Raiteri M., Bonanno G., Fedele E. Release of gamma-[3H]aminobutyric acid (GABA) from electrically stimulated rat cortical slices and its modulation by GABAB autoreceptors. J Pharmacol Exp Ther. 1989 Aug;250(2):648–653. [PubMed] [Google Scholar]
  18. Schlicker E., Classen K., Göthert M. GABAB receptor-mediated inhibition of serotonin release in the rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(2):99–105. doi: 10.1007/BF00517304. [DOI] [PubMed] [Google Scholar]
  19. Schlicker E., Fink K., Hinterthaner M., Göthert M. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):633–638. doi: 10.1007/BF00717738. [DOI] [PubMed] [Google Scholar]
  20. Schlicker E., Schunack W., Göthert M. Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs. Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):497–501. doi: 10.1007/BF00169035. [DOI] [PubMed] [Google Scholar]
  21. Starke K., Weitzell R. gamma-Aminobutyric acid and postganglionic sympathetic transmission in the pulmonary artery of the rabbit. J Auton Pharmacol. 1980 Nov;1(1):45–51. doi: 10.1111/j.1474-8673.1980.tb00440.x. [DOI] [PubMed] [Google Scholar]
  22. Suzdak P. D., Gianutsos G. Effect of chronic imipramine or baclofen on GABA-B binding and cyclic AMP production in cerebral cortex. Eur J Pharmacol. 1986 Nov 12;131(1):129–133. doi: 10.1016/0014-2999(86)90526-1. [DOI] [PubMed] [Google Scholar]
  23. Waldmeier P. C., Wicki P., Feldtrauer J. J., Baumann P. A. Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):289–295. doi: 10.1007/BF00168841. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES